Brandinium

Trademark search for:

LUXLAVIE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2021-11-29 — Application filed
  • 2022-02-17 — Sn assigned for sect 66a appl from ib
  • 2022-02-18 — Application filed
  • 2022-02-22 — Application filed
  • 2022-03-25 — Teas voluntary amendment received
  • 2022-03-29 — Assigned to lie
  • 2022-03-31 — Preliminary/voluntary amendment - entered
  • 2022-05-20 — Change of name/address rec'd from ib
  • 2022-09-08 — Assigned to examiner
  • 2022-09-14 — Final disposition recorded
  • 2022-09-15 — Office action issued
  • 2022-11-04 — Office action issued
  • 2022-11-04 — Office action issued
  • 2022-11-27 — Office action issued
  • 2023-03-18 — New representative at ib received
  • 2023-05-19 — Application abandoned
  • 2023-05-19 — Application abandoned
  • 2023-05-19 — Application abandoned
  • 2023-05-19 — Final status recorded
  • 2023-07-19 — Notification of possible opposition sent to ib
  • 2023-07-19 — Notification of possible opposition created, to be sent to ib
  • 2023-08-06 — Notification of possible opposition - processed by ib
  • 2024-05-20 — Final disposition recorded
  • 2024-05-20 — Final disposition recorded
  • 2024-06-11 — Final disposition recorded
  • 2024-11-15 — Limitation of goods received from ib
  • 2024-12-27 — New representative at ib received
  • 2025-06-05 — Limitation from the ib examined, no action is needed

Owner Information

Galderma Holding SA
CH

Correspondent

Camille M. Miller Cozen O'Connor
1650 Market Street, Suite 2800
One Liberty Place
Philadelphia, PA 19103

Filing Details

Filing Date:
2021-11-29
Status Date:
2023-05-19
Category:
Pharmaceuticals
Filing Year:
2021

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.